ADVANS PHARMA
Advans Pharma is a manufacturer of pharmaceutical products, including dermocosmetics, food supplements and healthcare products.
ADVANS PHARMA
Industry:
Cosmetics Dietary Supplements Food And Beverage Health Care Manufacturing Pharmaceutical
Founded:
2014-01-01
Address:
Tunis, Tunis, Tunisia
Country:
Tunisia
Website Url:
http://www.advanspharma.com
Total Employee:
11+
Status:
Active
Contact:
216-7177-2155
Email Addresses:
[email protected]
Technology used in webpage:
Apple Mobile Web Clips Icon Google Font API Google Maps Content Delivery Network Mobile Non Scaleable Content JsDelivr GStatic Google Static Content BootstrapCDN Apache 2.4 Debian
Similar Organizations
ADV Farma
ADV Farma manufactures pharmochemical and pharmaceutical products, offering a diverse range including personal care and respiratory aids.
Official Site Inspections
http://www.advanspharma.com
- Host name: cluster026.hosting.ovh.net
- IP address: 87.98.154.146
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Advans Pharma"
Advans Pharma - Crunchbase Company Profile & Funding
Organization. Advans Pharma . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number …See details»
Advanz Pharma - Wikipedia
Advanz Pharma Corp. is a British multinational pharmaceutical company headquartered in London. It changed its name from Concordia Healthcare Corp. in November 2018. The company focuses on a number of therapy areas including endocrinology, ophthalmology, urology, anti-infectives, pain management, central nervous system disorders, oncology, haematology, cardiology and intensive care medicineSee details»
About - ADVANZ PHARMA
The success of any company is driven by its people. We are no different. Our teams of more than 650 dedicated and experienced professionals who come from all walks of life and …See details»
ADVANZ PHARMA - LinkedIn
ADVANZ PHARMA will be attending CPHI 2024 in Milan, one of the world’s most influential events for the pharmaceutical industry. This global gathering provides the perfect platform for …See details»
- ADVANZ PHARMA
OAKVILLE, ON, Feb. 16, 2016 /CNW/ - Concordia Healthcare Corp. ("Concordia" or the "Company") (NASDAQ: CXRX) (TSX: CXR), an international pharmaceutical company …See details»
About | ADVANZ PHARMA Canada
Our organization possesses the commercial, market access, regulatory, and medical affairs capabilities that are necessary to deliver patient-centric solutions that add value to patients …See details»
ADVANZ PHARMA - JOIN US
Grow With Us ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines in Europe that is committed to improving the lives of patients by …See details»
ADVANZ PHARMA acquires global rights to Androcur® from Bayer
07.11.23. Androcur ® (cyproterone acetate) is sold in more than 60 markets across Europe, Canada, APAC, MENA, and Latin America; The acquisition leverages ADVANZ’s commercial …See details»
ADVANZ PHARMA makes key changes to senior leadership to …
18.11.21. Dr. Steffen Wagner appointed as new Chief Executive Officer and Andreas Stickler as new Chief Financial Officer LONDON, Nov. 18, 2021 /CNW/ - ADVANZ PHARMA Corp. …See details»
Contact | ADVANZ PHARMA Canada
Canadian affiliate office: ADVANZ PHARMA Canada Inc. 4263 Sherwoodtowne Blvd., Suite 300 Mississauga, ON L4Z 1Y5 Email: [email protected] Compliance hotline. …See details»
Welcome to ADVANZ PHARMA Canada
The success of any company is driven by it’s people. We are no different. We believe in creating a collaborative, supportive, and flexible working environment. Our highly experienced team is …See details»
ADVANZ PHARMA further strengthens its specialty and hospital …
03.10.22. ADVANZ PHARMA completes the acquisition of a hospital anti-infective portfolio from Sanofi, including the brands Azactamâ„¢, Cefotaxâ„¢, Claforanâ„¢, Colimycinâ„¢, Orokenâ„¢, …See details»
Going beyond Expectation | ADVANZ PHARMA
After acquiring them, we use our world class pharmaceutical expertise to extend their life, improving drug delivery for the benefit of patients, care givers and payors, whether that is …See details»
ADVANZ PHARMA to acquire Intercept’s business in Europe, …
05.05.22. Acquisition to strengthen ADVANZ PHARMA’s position as a partner of choice for commercialisation of specialty and hospital pharmaceuticals in EuropeSee details»
Alvotech and ADVANZ PHARMA Sign Commercialization …
18.06.24. ADVANZ PHARMA secures rights to commercialize Alvotech’s biosimilar candidate for Eylea® in Europe; ADVANZ PHARMA will leverage its existing specialty and hospital …See details»
Investors - ADVANZ PHARMA
Formal sale process. information regarding formal sale process. access to this area of the website may be restricted under securities laws in certain jurisdictions.See details»
ADVANZ PHARMA to receive exclusive rights from Applied …
04.01.23. ADVANZ PHARMA secures exclusive rights to register and commercialise AT-007, a Phase 3 development compound for the treatment of several rare neurological diseases, …See details»
Partner of Choice | ADVANZ PHARMA
Licensing. We are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. We are especially interested in licensing the rights …See details»
ADVANZ PHARMA further strengthens its global portfolio of …
18.10.23. ADVANZ PHARMA closes the acquisition of global rights to Tostran® from Kyowa Kirin; ADVANZ PHARMA signs agreement to acquire Progynova® and Cyclo-Progynova® in …See details»